Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrogen Bromide | HCID 260 | — |
| Reactant | HCID 68500258 | HCID 68500258 | — |
| Product | HCID 66731886 | HCID 66731886 | 71% |
Reaction Steps
(2R,4S)-methyl 2-(2,5-difluorobenzyl)-4-(3-oxo-2,3-dihydroisoxazol-5-yl)piperidine-1-carboxylate (505 mg, 1.43 mmol) was dissolved in hydrogen bromide (33% in acetic acid, 10 mL, 57.10 mmol) and the mixture stirred at room temperature for 22 h. The solvent was evaporated and the residue purified by preparative HPLC (Instrument: FractionLynx III, Mobilphase: gradient 5-95% MeCN in 0.2% NH3, pH 10, Column: Xbridge Prep C18 5 μm OBD 19*150 mm) to yield 5-((2R,4S)-2-(2,5-difluorobenzyl)piperidin-4-yl)isoxazol-3(2H)-one 299 mg (71%). 1H NMR (600 MHz, cd3od) δ 1.49 (q, 1H), 1.71 (dq, 1H), 1.99-2.08 (m, 2H), 2.82-3.00 (m, 4H), 3.24-3.31 (m, 1H), 3.31-3.37 (m, 1H), 5.50 (s, 1H), 6.99-7.13 (m, 3H). HRMS Calculated for [C15H16F2N2O2+H]+: 295.1258. Found: 295.1244
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08415378B2 |
|---|
| Source dataset | uspto-grants-2013_04 |
|---|
| ORD ID | ord-44a5038ecc54422dbe71984ba4b56cdf |
|---|
| Source note | uspto-grants-2013_04 |
|---|